Concepedia

Peter Sondermann

PS

24

Publications

4.3K

Citations

20

H-Index

1999

Active since

Affiliations

Max Planck Institute of Biochemistry(Current)

Roche (Switzerland)

Roche Pharma AG (Germany)

University of Groningen

University Medical Center Groningen

Peter Sondermann is an author at Max Planck Institute of Biochemistry specializing in medicine, cell biology, and immunology.

Top concepts

Publications per year

1999–2023

24

Publications

24

Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell–mediated B-cell cytotoxicity

Ekkehard Mössner, Peter Brünker, Samuel Moser et al. · Blood · 2010 · 929 citations · Full text

Unique carbohydrate–carbohydrate interactions are required for high affinity binding between FcγRIII and antibodies lacking core fucose

Claudia Ferrara, Sandra Grau, Christiane Jäger et al. · Proceedings of the National Academy of Sciences · 2011 · 735 citations

, , +20

The 3.2-Å crystal structure of the human IgG1 Fc fragment–FcγRIII complex

Peter Sondermann, Robert Huber, Vaughan Oosthuizen et al. · Nature · 2000 · 707 citations

, , +5

The Carbohydrate at FcγRIIIa Asn-162

Claudia Ferrara, Fiona Stuart, Peter Sondermann et al. · Journal of Biological Chemistry · 2005 · 344 citations · Full text

Role of Oligosaccharide Residues of IgG1-Fc in FcγRIIb Binding

Yusuke Mimura, Peter Sondermann, Rodolfo Ghirlando et al. · Journal of Biological Chemistry · 2001 · 235 citations · Full text

Rows per page

1–5 of 24